A cDNA encoding a novel fatty acid transport protein (FATP) was identified recently using expression cloning methodologies.
We have studied the expression of FATP in differentiating 3T3-Ll cells and adipose tissue in viva. When 3T3-Ll preadipocytes are treated with a combination of methylisobutylxanthine, dexamethasone, and insulin to induce differentiation, the abundance of FATP mRNA decreases within 24 h to less than one-third that of preadipocytes and increases subsequently, such that mature adipocytes have 6-7 times more FATP mRNA than fibroblastic precursors.
In fully differentiated 3T3-Ll adipocytes, insulin alone is sufficient to down-regulate FATP mRNA levels lofold. The concentration of insulin necessary for half-maximal repression (I& is -1 nM and is specific for insulin; insulin-like growth factor I (IGF-I) has little effect at similar concentrations. Kinetic analysis indicates that the reduction in expression of FATP mRNA by insulin is rapid (t-h = -4 h) and reversible upon withdrawal of insulin. The half-lives of FATP mRNA are 2.9 h and 4.4 h in the absence and presence of insulin, respectively. The insulinmediated decrease in FATP steady state mRNA level correlates with a decrease in its transcription rate as measured by nuclear run-on transcription assay. To determine whether physiological conditions that alter insulin concentration in vivo affect adipose FATP levels, feeding/fasting studies are employed.
Fasting of C57BV6J mice for 48 h results in an 11-fold up-regulation of FATP mRNA expression in adipose tissue. Refeeding of fasted animals for 72 h results in a return of FATP mRNA to basal levels. In sum, these results indicate that the expression of FATP gene is negatively regulated by insulin at the transcriptional level in cultured adipocytes and that transporter mRNA expression in murine adipose tissue is altered in a
INTRODUCTION
The molecular basis for long chain fatty acid transport across biological membrane has remained enigmatic despite intense examination. Fatty acids may diffuse rapidly across membranes due to the solubility of the lipid in mixed-phospholipid bilayers (1). The cellular uptake of fatty acids may therefore be driven by mass action based upon cellular metabolism. Alternatively, a protein(s) may mediate the transfer of fatty acids across the membrane.
In support of a protein-mediated mechanism, transport activity in adipocytes has been characterized as a high-affinity process (K, of 200 nM) that is inhibited by fatty acid analogs, is sensitive to prior protease treatment of the cell surface, and is blocked by antibodies directed toward specific plasma membrane proteins (2-6). Recently, several proteins have been proposed to function as fatty acid transporters.
The first, plasma membrane fatty acid binding protein (FABPpm) is biochemically indistinguishable from the mitochondrial matrix enzyme aspartate aminotransferase (mAspAT) (7). A cDNA clone for the 43-kDa FABPpm has not been described; however, stable 3T3 cell lines overexpressing mAspAT exhibit a lo-fold increase in oleate uptake. A polyclonal antibody directed against FABPpm stains the periphery of mAspAT-expressing cell lines (10). Despite this evidence, it remains unclear how a soluble mitochondria protein may be directed to the plasma membrane and how it might function as a transporter.
The second, fatty acid translocase (FAT), is an 88-kDa adipocyte plasma membrane glycoprotein with two predicted transmembrane domains. FAT is the murine adipocyte homolog of the human CD36 cell surface antigen. N-Sulfosuccinimidyl long-chain fatty acid derivatives bind FAT and inhibit fatty acid 
RESULTS

FATP mRNA Expression during 3T3-Ll Differentiation
During adipocyte differentiation, numerous genes encoding lipogenic and lipolytic enzymes and proteins responsible for the adipocyte phenotype are transcriptionally activated and expressed (12, 13). To determine whether the expression of FATP follows a similar kinetic progression, Northern blotting was used to probe RNAs isolated at various days during the differentiation program. As shown in Fig. 1 , FATP mRNA is present at low levels in the 3T3-Ll preadipocytes, decreases by two-thirds during days 1 and 2 of differentiation, and then increases 5-to 7-fold above the level at day 0 as the cells reach their fully differentiated state (day 9). The low level of FATP expression in 3T3-Ll preadipocytes is similar to that observed in nondifferentiating 3T3-C2 cells and NIH 3T3 cells (data not shown), suggesting that FATP is expressed at low levels in a number of cell types and may be involved ubiquitously in basal lipid transport. In contrast, the mRNA for the adipocyte lipid binding protein (ALBP), is expressed only in differentiated adipocytes. During the initial stage of differentiation, the decrease in FATP mRNA occurs after exposure to insulin, MIX, and DEX. This observation suggests that one or more of the factors may control FATP gene expression. Because our interests were on the control of FATP in fat cells, we turned our attention to those factors that may regulate FATP expression in mature 3T3-Ll adipocytes. 3T3-Ll adipocytes (day 9) were incubated with all possible combinations of the factors for 24 h and the levels of FATP mRNA were assessed by Northern analysis. As shown in Fig. 2 , insulin and MIX each down-regulate FATP expression and, when incubated together, their effects are additive. The inclusion of FBS had no effect on FATP expression (results not shown). While the effects of DEX tended to antagonize those of insulin, no statistical significance to the results could be assigned.
Regulation of FATP mRNA Expression by Insulin in 3T3-Li Adipocytes
To explore further the effects of insulin on FATP expression in adipocytes, the concentration dependence of insulin-mediated down-regulation was investigated. The concentration of insulin necessary for 50% decrease in steady-state mRNA level is approximately 1 nM ( Fig. 3) . At the highest insulin concentrations (>lOO r-r@, the FATP mRNA level decreases to 20% of the untreated control sample. In the presence of 10% FBS, higher concentrations of insulin are needed to achieve the same magnitude of repression (results not shown). IGF-I at a concentration of 100 nM is not as effective in reducing FATP mRNA levels, which are 60% that of the control untreated samples (Fig. 3) .
The kinetics of insulin-mediated down-regulation of FATP expression were further examined. A time course shows that at 4 h after insulin treatment FATP mRNA decreases by 50% and at 8 h by 90% (maximal) (Fig. 4 ). Continued treatment with insulin to 48 h results in a small increase in FATP mRNA to 40% of control (results not shown), which may be due to the development of insulin resistance in these cells (14). To determine whether the insulin-mediated downregulation of FATP expression was reversible, cultured 3T3-Ll adipocytes were first treated with insulin to decrease FATP mRNA level. After 12 h of insulin treatment, insulin was withdrawn and cells were maintained in the absence of insulin. Under these conditions, FATP mRNA levels increase within 2 h after insulin withdrawal and reach 70% of the control level after 8 h (Fig. 5) . Therefore, in the absence of insulin, the expression of FATP mRNA returns to essentially basal levels.
Nuclear run-on assays were used to estimate the relative rate of FATP gene transcription as a consequence of insulin treatment. After insulin addition to cultured 3T3-Ll adipocytes, nuclei were isolated and nascent transcripts elongated in the presence of [a-32P]UTP. The radioactive RNA was isolated and hybridized to DNA probes affixed to nylon membranes. The relative transcription rates were calculated as a function of time after insulin addition and normalized to the hybridization of labeled RNA to total genomic DNA. As shown in Fig. 4 , the rate of FATP transcription decreases within 1.5 h after insulin addi- Days after initiation of differentiation tion. The decrease in FATP gene transcription occurs at a rate greater than that of its cognate mRNA, suggesting that insulin down-regulates the expression of FATP at the transcriptional level. Using 5 pg/ml actinomycin D to block transcription by RNA polymerase II, the half-life of the FATP message is determined to be 2.9 h (n = 4). Insulin does not accelerate the degradation of FATP message, but rather slightly increases its half-life to 4.4 h (n = 3). In order to study the down-regulation of the insulin-responsive glucose transporter (GLUT 4) by polyunsaturated fatty acids, Tebbey et al. (15) 
olism (16-19). During a short-term starvation, insulin level declines markedly, then returns to basal level after a refeeding period (19)
. After a 48-h fast, FATP mRNA in murine adipose tissue increases 1 l-fold above control level (Fig. 6) . After refeeding for 72 h, the FATP mRNA level declines to control level. In contrast, the levels of FATP mRNA in brain remain unaltered during the nutritional shift experiment (results not shown). Thus, the dietary control of FATP expression is tissue-specific and consistent with a negative regulatory effect of insulin on FATP gene expression.
DISCUSSION
The molecular cloning of the cDNA encoding the adipocyte FATP has allowed for new initiatives into the biochemistry of lipid transport. Because the typical diet consists of 35-45% fats, the disposal of dietary lipids is an important process for overall body energy balance. FATP is presumed to facilitate the flux of fatty acids across the plasma membrane of several target tissues, including cardiac and skeletal muscle as well as fat. It is possible that mAspAT and FAT also contribute to fatty acid flux across the plasma membrane (8, lo), and the relationship of these proteins to FATP remains to be determined.
Fatty acid flux across the adipocyte plasma membrane is bidirectional in response to different metabolic conditions.
For example, fatty acids are transported into the adipocyte during nutrient abundance where they are activated with coenzyme A and condensed with a-glycerol phosphate to form the storage lipid, triacylglycerol.
Insulin promotes fatty acid and triacylglycerol synthesis as well as glucose transport, all factors leading to the storage of metabolic energy in the form of the lipid droplet (20). In contrast, when nutritional supplies are diminished, adipose lipolysis is activated by a p-adrenergic receptor-coupled system that activates CAMP-dependent protein kinase, ultimately resulting in the phosphorylation of the hormone-sensitive lipase. The activated hormone-sensitive lipase hydrolyzes triacylglycerol to generate intracellular fatty acids that are transported out of the cell where they are bound by albumin and transported to other tissues for metabolism (21). Insulin is antilipolytic, i.e., it inhibits the flow of fatty acids out of the fat cell. The adipocyte FATP was cloned by Schaffer and Lodish (9) based upon its ability to internalize fatty acids. Our findings of the repression of FATP transcription by insulin and superinduction during fasting suggest that FATP may function to facilitate fatty acid efflux from the fat cell during lipolytic conditions.
The induction of FATP expression during 3T3-Ll adipocyte differentiation is similar to increases in expression of ALBP and adipsin, two classical markers MOL END0 '1996 1026 Vo110No.8 for fat tissue. However, FATP is expressed at low levels in preadipocytes and cannot be considered strictly adipocyte-specific.
Adipose conversion has been shown to be intimately connected to the expression of immediate early transcription factors such as CCAAT-enhancer binding protein-a (C/EBPa) and peroxisome proliferator activated receptor-y2 (22,23). Experimental models suggest that the transcription factor peroxisome proliferator activated receptor-y2 associates with a lipophilic ligand early during the differentiation process, suggested to be the prostaglandin J, metabolite, 15deoxy A'2~'4-PGJ2, to activate the differentiation program (24, 25). Since FATP is expressed at low levels in preadipocytes, it may facilitate uptake of a fatty acid substrate required early during adipose conversion.
Our experiments have established insulin as a negative regulator of FATP expression. This regulation is rapid (-8 h for maximal response) and insulin-specific given the low concentration (-1 r-t@ of insulin but much higher concentration (~100 nM) of IGF-I needed for 50% down-regulation.
Nuclear run-on transcription assays and actinomycin D experiments suggest that the decrease in FATP mRNA level is primarily due to a decrease in gene transcription.
In addition, the insulinmediated down-regulation of FATP mRNA levels is compromised by the inclusion of cycloheximide in the medium (results not shown). This suggests that new protein synthesis may be required for insulin-induced down-regulation of FATP mRNA levels although alternate explanations have not been ruled out. FATP transcription is also down-regulated by CAMP but not by other hormones known to affect lipid metabolism such as T3 (results not shown).
Negative regulation of gene expression by insulin has been the focus of studies in several systems. The mRNA levels of insulin like growth factor binding protein-l (IGFBP-1) (26) and the gluconeogenic enzymes, phosphoenolpyruvate carboxykinase (PEPCK) (26) and glucose-6-phosphatase (27), are all reduced by insulin. In addition, PEPCK (28) glucose transporter-4 (GLUT4) (15), microsomal triglyceride transfer protein (29), and IGFBP-1 (30) have all been shown to be negatively regulated by insulin at the transcription level. The negative insulin responsive element may be a GC factor binding site conserved in upstream sequences of several insulin-responsive genes (31). However, the insulin response element in the PEPCK and IGFBP-1 genes has been characterized by the sequence 5'-TGGTGlllTG-3' (41), which forms the core of the hepatic nuclear factor 3 binding site (30). Interestingly, in preliminary analysis of the FATP gene upstream region, the sequence 5'-TGGTGCTTAG-3', which is very similar to the consensus insulin response element. is found - and/or decreased expression of C/EBPa. Since FATP is also rapidly repressed by insulin (50% inhibition at 4 h, 90% at 8 h), it is reasonable to consider that C/EBPa may also play a role in regulating FATP transcription.
Even though GLUT4 and FATP are regulated similarly in cultured adipocytes, differential responses are observed in fasted animals. For GLUT4, the CAMP effect is dominant over that of insulin; therefore, during fasting GLUT4 mRNA is down-regulated (16). For FATP, the effects of CAMP and insulin appear to be independent of each other; FATP mRNA is up-regulated during fasting.
In sum, we have described the expression of the fatty acid transporter mRNA during adipose conversion of 3T3-Ll preadipocytes in culture. We have demonstrated that in mature differentiated adipocytes the transcription of FATP is negatively regulated by insulin. Furthermore, FATP mRNA levels are increased during starvation, which is associated with low insulin levels. These results suggest insulin is a primary endocrine factor controlling expression of the murine fatty acid transporter.
Identification of the mechanistic basis for these effects of insulin may provide insight into lipid metabolism in fat cells and in pathophysiological conditions such as obesity and type II diabetes. the blots were washed in 2x SSPE (1 x SSPE = 0.15 M NaCI, 10 mM NaH,PO,, 1 mM EDTA) at 42 C once for 10 min, and in 2X SSPE and 0.1% SDS at 65 C twice for 20 min. The blots were exposed to Reflection x-ray film (DuPont, Boston, MA) at -70 C. Autoradiographs were scanned using a laser densitometer (Molecular Dynamics, Sunnyvale, CA 94086) and analyzed using NIH Image 1.54 software (38).
MATERIALS AND METHODS
Materials
Nuclei Isolation and Run-on Transcription
Nuclei from 3T3-Ll adipocytes were isolated and run-on transcription assays were carried out as described (39). Hybridization was carried out on slot-blots to either cDNA fragments or genomic DNA that had been affixed to Magna nylon membrane.
The extent of hybridization was quantified by laser densitometry and normalized to the hybridization of total genomic DNA as an internal standard.
Experimental Animals C57BU6J mice (7-9 weeks old, mixed sexes) from Jackson Laboratory (Bar Harbor, ME) were used. One group of mice (three animals) was subjected to a 48-h solid-food fast while a second group (three animals) was fasted 48 h followed by a 72-h refeeding period with rodent laboratory chow (4.5% fat, 23.4% protein, 5.8% fiber). A third group of mice (three animals) was fed ad libitum and used as a control.
All mice were housed in identical conditions and were taken in the morning to avoid introducing diurnal variations. Mice (fasted, fasted and refed, control)
were killed by cervical dislocation and tissues were immediately harvested. All tissues were snap-frozen in liquid nitrogen and stored at -70 C until RNA was isolated.
All use of animals was approved by the institutional animal care committee.
